Hydrogels: Synthesis, Characterization and Applications (2nd Edition)

A special issue of Gels (ISSN 2310-2861). This special issue belongs to the section "Gel Processing and Engineering".

Deadline for manuscript submissions: 31 May 2024 | Viewed by 668

Special Issue Editors


E-Mail Website
Guest Editor
School of Chemical Engineering and Technology (SCET), Xi’an Jiaotong University, Xi’an 710049, China
Interests: biomaterials; hyperbranched polymers; cyclized polymers; non-viral gene vector; controlled/living polymerization
Special Issues, Collections and Topics in MDPI journals
College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China
Interests: gene therapy; mRNA delivery; lipid nanoparticles; gene editing; biomaterials
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Hydrogels, due to their biomimetic nature, have been widely explored for application in regenerative medicine. With the advancements in chemistry, biology and material sciences, diverse new methods for the synthesis and characterization of hydrogels have been proposed; the chemical compositions, topological structures and functionalities of hydrogels can be manipulated more effectively; and the physiological properties and biological functions of hydrogels can be further tailor-made and greatly enhanced. Correspondingly, the utility of hydrogels in regenerative medicine, in terms of tissue engineering, drug delivery and diagnosis, etc., have been intensively assessed, both in vitro and in vivo. This progress in the field has brought hydrogels ever closer to achieving their potential in regenerative medicine. Meanwhile, new challenges associated with translating hydrogels from bench to bedside have also emerged. In this Special Issue, we aim to highlight the most recent progress in the synthesis, characterization and application of hydrogels in regenerative medicine, with the expectation to provide new insights into the development of clinical applicable hydrogels. We invite original research articles and review papers that cover the emerging methods for synthesizing and characterizing hydrogels, new strategies in tailoring the chemical compositions, functionalities and properties of hydrogels, the in vitro and in vivo performance of hydrogels in tissue engineering, drug delivery and diagnosis, etc., and potential challenges in translating hydrogels to clinical settings.

Prof. Dr. Dezhong Zhou
Dr. Shuai Liu
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Gels is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • regenerative medicine
  • biomaterials
  • hydrogels
  • tissue engineering
  • drug delivery
  • diagnosis

Related Special Issue

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

26 pages, 8628 KiB  
Article
Novel Injectable Hydrogel Formulations and Gas Chromatography Analysis of the Residual Crosslinker in Formulations Intended for Pharmaceutical and Cosmetic Applications
by Fatimah Rashid, Paul Carter and Stephen Childs
Gels 2024, 10(4), 280; https://doi.org/10.3390/gels10040280 - 21 Apr 2024
Viewed by 427
Abstract
Novel hyaluronic acid (HA) crosslinked with pentaerythritol tetra-acrylate (PT) injectable hydrogels was invented. These injectable hydrogel/dermal filler formulations were synthesised using HA and the acrylate PT as a crosslinker under basic pH conditions using thermal crosslinking methods (oven heating), which provides a simple, [...] Read more.
Novel hyaluronic acid (HA) crosslinked with pentaerythritol tetra-acrylate (PT) injectable hydrogels was invented. These injectable hydrogel/dermal filler formulations were synthesised using HA and the acrylate PT as a crosslinker under basic pH conditions using thermal crosslinking methods (oven heating), which provides a simple, safe, and eco-friendly method for crosslinking in 4 h under 45 °C. Fourier-transform infrared spectroscopy (FTIR) and scanning electron microscopy (SEM) analyses were conducted to represent the difference between the formulations in terms of peak formation and pore size, respectively. The crosslinking was partial as is considered to be typical for dermal injectable fillers. The rheological properties of these formulations showed that these novel dermal injectables are highly promising, and the newly developed fillers could be used with better results for dermal anti-wrinkle corrections, shaping, and volumising reasons. Furthermore, crosslinker (PT) residual analysis was carried out to state the formulations that are valid and acceptable for intradermal usage. The results from the GC method validation revealed it was a suitable method for this study. The GC analysis of all five injectable hydrogel/filler formulations demonstrated the formulations HA-PT 1, 2, 3 and 4 were formulated using (0.05–0.1)% w/w PT containing residual PT monomers within the safe limits that were determined to be below (0.008% w/w). This work has shown the development of a novel injectable hydrogel/filler formulation for pharmaceutical and cosmetic applications can be prepared in a more sustainable and simple way using pentaerythritol tetra-acrylate as a crosslinker agent, which holds great promise for the industry’s future advancement. Full article
(This article belongs to the Special Issue Hydrogels: Synthesis, Characterization and Applications (2nd Edition))
Show Figures

Graphical abstract

Back to TopTop